Madhusudan Grover

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. pmc Role of gut pathogens in development of irritable bowel syndrome
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Indian J Med Res 139:11-8. 2014
  2. doi request reprint When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 14:290-6. 2012
  3. doi request reprint Functional abdominal pain
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 12:391-8. 2010
  4. doi request reprint Centrally acting therapies for irritable bowel syndrome
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Gastroenterol Clin North Am 40:183-206. 2011
  5. pmc Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit
    Michael Camilleri
    Mayo Clinic, Charlton 8 110, 200 First St S W, Rochester, MN 55905
    Am J Physiol Gastrointest Liver Physiol 306:G13-26. 2014
  6. pmc Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases
    Madhusudan Grover
    Clinical Enteric Neuroscience Translational and Epidemiological Research CENTER, College of Medicine, Mayo Clinic, 200 First St S W, Charlton 8 110, Rochester, MN 55905, USA
    J Gastroenterol 48:177-81. 2013

Collaborators

Detail Information

Publications6

  1. pmc Role of gut pathogens in development of irritable bowel syndrome
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
    Indian J Med Res 139:11-8. 2014
    ..It is plausible that alteration in the commensal microbiome persists in a subset of patients predisposing them to develop PI-IBS. ..
  2. doi request reprint When is irritable bowel syndrome not irritable bowel syndrome? Diagnosis and treatment of chronic functional abdominal pain
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 14:290-6. 2012
    ..A comprehensive approach to management using a biopsychosocial construct and collaboration with pain specialists and psychiatry is most beneficial to the management of this disorder...
  3. doi request reprint Functional abdominal pain
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 12:391-8. 2010
    ..These factors make it critical to use a biopsychosocial construct to understand and manage FAPS, because gut-directed treatments are usually not successful in managing this condition...
  4. doi request reprint Centrally acting therapies for irritable bowel syndrome
    Madhusudan Grover
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA
    Gastroenterol Clin North Am 40:183-206. 2011
    ....
  5. pmc Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit
    Michael Camilleri
    Mayo Clinic, Charlton 8 110, 200 First St S W, Rochester, MN 55905
    Am J Physiol Gastrointest Liver Physiol 306:G13-26. 2014
    ..027) and rs1966265 with 24-h colonic transit (P = 0.066). Thus exome sequencing identified additional variants in KLB and FGFR4 associated with bile acids or colonic transit in IBS-D. ..
  6. pmc Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases
    Madhusudan Grover
    Clinical Enteric Neuroscience Translational and Epidemiological Research CENTER, College of Medicine, Mayo Clinic, 200 First St S W, Charlton 8 110, Rochester, MN 55905, USA
    J Gastroenterol 48:177-81. 2013
    ..Antidepressants appear to be more effective in the treatment of patients with anxiety or depression, but larger prospective trials assessing both clinical and pharmacodynamic effects on gut sensorimotor function are needed...